ALLO
Price
$1.05
Change
-$0.01 (-0.94%)
Updated
Aug 7 closing price
Capitalization
229.67M
5 days until earnings call
RXRX
Price
$5.41
Change
-$0.07 (-1.28%)
Updated
Aug 7 closing price
Capitalization
2.35B
89 days until earnings call
Interact to see
Advertisement

ALLO vs RXRX

Header iconALLO vs RXRX Comparison
Open Charts ALLO vs RXRXBanner chart's image
Allogene Therapeutics
Price$1.05
Change-$0.01 (-0.94%)
Volume$8.57M
Capitalization229.67M
Recursion Pharmaceuticals
Price$5.41
Change-$0.07 (-1.28%)
Volume$14.34M
Capitalization2.35B
ALLO vs RXRX Comparison Chart in %
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. RXRX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ALLO: $1.05 vs. RXRX: $5.41)
Brand notoriety: ALLO and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 229% vs. RXRX: 46%
Market capitalization -- ALLO: $229.67M vs. RXRX: $2.35B
ALLO [@Biotechnology] is valued at $229.67M. RXRX’s [@Biotechnology] market capitalization is $2.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 3 bullish TA indicator(s).

  • ALLO’s TA Score: 3 bullish, 7 bearish.
  • RXRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than ALLO.

Price Growth

ALLO (@Biotechnology) experienced а -14.63% price change this week, while RXRX (@Biotechnology) price change was -9.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 13, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.35B) has a higher market cap than ALLO($230M). RXRX YTD gains are higher at: -19.970 vs. ALLO (-50.704). ALLO has higher annual earnings (EBITDA): -238.37M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. ALLO (280M). ALLO has less debt than RXRX: ALLO (81.3M) vs RXRX (92.9M). RXRX has higher revenues than ALLO: RXRX (59.8M) vs ALLO (0).
ALLORXRXALLO / RXRX
Capitalization230M2.35B10%
EBITDA-238.37M-524.77M45%
Gain YTD-50.704-19.970254%
P/E RatioN/AN/A-
Revenue059.8M-
Total Cash280M500M56%
Total Debt81.3M92.9M88%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLORXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VFAIX63.55N/A
N/A
Vanguard Financials Index Admiral
POVYX31.21N/A
N/A
Putnam International Equity Y
PRNEX39.79N/A
N/A
T. Rowe Price New Era
AQLGX17.55N/A
N/A
Alta Quality Growth Institutional
DVRPX17.63N/A
N/A
UBS US Dividend Ruler P2

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with CRSP. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
-0.94%
CRSP - ALLO
56%
Loosely correlated
-0.67%
FATE - ALLO
55%
Loosely correlated
-5.63%
NTLA - ALLO
53%
Loosely correlated
+0.88%
BEAM - ALLO
52%
Loosely correlated
-2.40%
RXRX - ALLO
49%
Loosely correlated
-1.28%
More